CD8A and neoplasm: These Th1 cytokines have documented anti-tumor effects including upregulation of MHC class I molecules on the surface of tumor cells promoting recognition by cytotoxic CD8+ T cells [272,273], induction of cell cycle arrest and apoptosis in tumor cells [274,275], and facilitation of anti-tumor Th1 cell differentiation [276,277].